Medical Patent News

RSS

Endo, Watson reach agreement to resolve two LIDODERM patent infringement lawsuits

Endo announced today that it has reached an agreement with Watson Pharmaceuticals (Watson) resolving two patent infringement lawsuits related to LIDODERM.

30 May 2012

USPTO issues patent to Corgenix’s AspirinWorks technology

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has been issued an additional U.S. patent covering its AspirinWorks technology.

30 May 2012

EPO issues patent to Cytune’s CYP0150 for treatment of cancer

Cytune Pharma, an emerging leader in innovative immunomodulatory agents against cancer and infectious diseases, announced today that it will attend the BIO2012 to present its major achievements over the last 12 months and to foster partnering discussions.

30 May 2012

Short hairpin RNAi gene silencing technology receives CSIRO's foundational patents

Australia's leading science agency, the Commonwealth Scientific and Industrial Research Organisation (CSIRO), has been granted foundational patents in the US and Europe for short hairpin RNAi (shRNA) gene silencing technology.

29 May 2012

Manufacturers of hearing aids, Acacia enter settlement and patent license agreements

Acacia Research Corporation announced today that its Adaptive Sonics LLC subsidiary has entered into settlement and patent license agreements with manufacturers of hearing aids.

29 May 2012

Watson, Endo and Teikoku Seiyaku enter settlement agreement to resolve Lidoderm patent litigation

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has entered into an agreement with Endo Pharmaceuticals Inc. and Teikoku Seiyaku Co., Ltd to settle all outstanding patent litigation related to Watson's generic version of Lidoderm.

29 May 2012

Auxilium, FCB I file suit against Watson over generic Testim

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone Gel, 1%. Watson's 1% testosterone gel product is a generic version of Auxilium Pharmaceuticals, Inc.'s Testim 1%.

25 May 2012

USPTO issues patent to QRxPharma’s MoxDuo for treatment of acute and chronic pain

QRxPharma Limited announced today that the United States Patent and Trademark Office (USPTO) issued the Company U.S. Patent No. 8,182,837, which does not expire until 2023.

24 May 2012

USPTO issues patent to MicuRx’s MRX-I antibacterial agent

MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that the U.S. Patent and Trademark Office (USPTO) issued a composition of matter patent covering its clinical candidate, MRX-I. MRX-I is a novel antibacterial oxazolidinone that targets infections due to multi-drug resistant Gram-positive pathogens.

23 May 2012

USPTO issues patent to Vandalia’s process for large-scale DNA production technology

Vandalia Research, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 8,163,489, covering Vandalia's process for large-scale DNA production using polymerase chain reaction.

18 May 2012

Codexis receives U.S. patent for enzymes utilized in HCV therapeutics

Codexis, Inc., a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the United States Patent and Trademark Office (USPTO) has granted Codexis' patent covering the biocatalysts and biocatalytic processes used to make key pharmaceutical intermediates in the synthesis of leading hepatitis-C therapeutics.

16 May 2012

Lab21’s HCV drug resistance genotyping receives new patents in the U.S., Europe

Lab21 Limited, the Cambridge, UK-based specialist in personalised medicine has secured new patents in Europe and the USA relating to Hepatitis C (HCV) drug resistance as it continues to expand its intellectual property portfolio in infectious disease testing.

15 May 2012

OPKO receives U.S. patent allowance titled, ‘Flow Control in Microfluidic Systems’

OPKO Health, Inc. today announced the receipt of a patent allowance from the U.S. Patent and Trademark Office (USPTO) for the patent application titled "Flow Control in Microfluidic Systems".

15 May 2012

Helico reaches patent litigation settlement with Pacific Biosciences

Helicos BioSciences Corporation announced today that it has settled its patent infringement litigation against Pacific Biosciences, Inc.

15 May 2012

USPTO issues new patent to Excelsior Medical's SwabKIT

Excelsior Medical Corporation announced that the United States Patent and Trademark Office (USPTO) has issued new US Patent No. 8,167,847 to the company. The patent relates to an antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly.

15 May 2012

Trovagene receives European patent titled, ‘Methods for Detection of Nucleic Acid Sequences in Urine’

Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced it has received notice of issuance of European Patent No. 2216416 entitled "Methods for Detection of Nucleic Acid Sequences in Urine."

11 May 2012

Shire, Cosmo and Giuliani International file suit against Watson over generic Lialda

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Mesalamine Delayed-release Tablets, 1.2g. Watson's ANDA product is a generic version of Shire Development LLC's Lialda.

10 May 2012

Integral Molecular receives U.S. patent for methodology that generates Lipoparticles

Integral Molecular, a leader in membrane protein reagents and services, announces the issuance of a key patent protecting its methodology for generating Lipoparticles, which provide highly-concentrated membrane proteins in their native conformation for antibody and drug discovery applications focused on membrane protein targets such as G protein-coupled receptors (GPCRs), ion channels, and transporters.

4 May 2012

Medical Brands' cranberry-based oral capsule granted Class IIa medical device status

Medical Brands has obtained a Class IIa medical device status through the appropriate Competent Authorities for Cranberry-Active, a patented cranberry-based oral capsule clinically shown to support urinary tract health.

2 May 2012

Inovio's SynCon vaccine for cervical dysplasias and cancers granted U.S. patent

Inovio Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 8,168,769, covering Inovio's SynCon vaccine for cervical dysplasias and cancers caused by human papillomavirus (HPV).

2 May 2012

Medical Patent News

Endo, Watson reach agreement to resolve two LIDODERM patent infringement lawsuits

USPTO issues patent to Corgenix’s AspirinWorks technology

EPO issues patent to Cytune’s CYP0150 for treatment of cancer

Short hairpin RNAi gene silencing technology receives CSIRO's foundational patents

Manufacturers of hearing aids, Acacia enter settlement and patent license agreements

Watson, Endo and Teikoku Seiyaku enter settlement agreement to resolve Lidoderm patent litigation

Auxilium, FCB I file suit against Watson over generic Testim

USPTO issues patent to QRxPharma’s MoxDuo for treatment of acute and chronic pain

USPTO issues patent to MicuRx’s MRX-I antibacterial agent

USPTO issues patent to Vandalia’s process for large-scale DNA production technology

Codexis receives U.S. patent for enzymes utilized in HCV therapeutics

Lab21’s HCV drug resistance genotyping receives new patents in the U.S., Europe

OPKO receives U.S. patent allowance titled, ‘Flow Control in Microfluidic Systems’

Helico reaches patent litigation settlement with Pacific Biosciences

USPTO issues new patent to Excelsior Medical's SwabKIT

Trovagene receives European patent titled, ‘Methods for Detection of Nucleic Acid Sequences in Urine’

Shire, Cosmo and Giuliani International file suit against Watson over generic Lialda

Integral Molecular receives U.S. patent for methodology that generates Lipoparticles

Medical Brands' cranberry-based oral capsule granted Class IIa medical device status

Inovio's SynCon vaccine for cervical dysplasias and cancers granted U.S. patent

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News